Exploiting the Endogenous Ubiquitin Proteasome System in Targeted Cancer Treatment

SIMPLE SUMMARY: The design of specific targeting reagents/drugs still remains a major goal in cancer treatment, with the aim of directing therapeutic agents into cancer cells, while avoiding damage to normal tissues and without evoking an immune response. One way to deal with this problem is to use...

Descripción completa

Detalles Bibliográficos
Autores principales: Hauser, Noa, Hirbawi, Joud, Saban Golub, Meshi, Zabit, Samar, Lichtenstein, Michal, Lorberboum-Galski, Haya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9818074/
https://www.ncbi.nlm.nih.gov/pubmed/36612252
http://dx.doi.org/10.3390/cancers15010256

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9818074/
https://www.ncbi.nlm.nih.gov/pubmed/36612252
http://dx.doi.org/10.3390/cancers15010256

Ejemplares similares